FDA Import Refusal AEK-0351230-6/21/1 — Korea Otsuka Pharmaceuticals
The FDA refused shipment AEK-0351230-6/21/1 from Korea Otsuka Pharmaceuticals (South Korea) on Feb 25, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75
Refusal details
- Date
- Feb 25, 2022
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75